Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.9918 |
High Similarity |
NPD3027 |
Phase 3 |
0.907 |
High Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.907 |
High Similarity |
NPD1613 |
Approved |
0.876 |
High Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.8682 |
High Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.8516 |
High Similarity |
NPD2982 |
Phase 2 |
0.8516 |
High Similarity |
NPD2983 |
Phase 2 |
0.8512 |
High Similarity |
NPD228 |
Approved |
0.8438 |
Intermediate Similarity |
NPD2981 |
Phase 2 |
0.8397 |
Intermediate Similarity |
NPD3018 |
Phase 2 |
0.8374 |
Intermediate Similarity |
NPD5283 |
Phase 1 |
0.8231 |
Intermediate Similarity |
NPD4379 |
Clinical (unspecified phase) |
0.8195 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.8095 |
Intermediate Similarity |
NPD1934 |
Approved |
0.8088 |
Intermediate Similarity |
NPD3619 |
Clinical (unspecified phase) |
0.8088 |
Intermediate Similarity |
NPD3620 |
Phase 2 |
0.8077 |
Intermediate Similarity |
NPD1610 |
Phase 2 |
0.8074 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.8049 |
Intermediate Similarity |
NPD3021 |
Approved |
0.8049 |
Intermediate Similarity |
NPD3022 |
Approved |
0.8047 |
Intermediate Similarity |
NPD1548 |
Phase 1 |
0.7919 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.7887 |
Intermediate Similarity |
NPD3060 |
Approved |
0.7852 |
Intermediate Similarity |
NPD37 |
Approved |
0.7846 |
Intermediate Similarity |
NPD1357 |
Approved |
0.7829 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.7826 |
Intermediate Similarity |
NPD1558 |
Phase 1 |
0.7823 |
Intermediate Similarity |
NPD1653 |
Approved |
0.7823 |
Intermediate Similarity |
NPD2684 |
Approved |
0.7815 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.7806 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.7806 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.7806 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.78 |
Intermediate Similarity |
NPD2801 |
Approved |
0.7778 |
Intermediate Similarity |
NPD5307 |
Clinical (unspecified phase) |
0.7778 |
Intermediate Similarity |
NPD6917 |
Clinical (unspecified phase) |
0.777 |
Intermediate Similarity |
NPD4005 |
Discontinued |
0.7746 |
Intermediate Similarity |
NPD3540 |
Phase 1 |
0.7746 |
Intermediate Similarity |
NPD7266 |
Discontinued |
0.7737 |
Intermediate Similarity |
NPD4625 |
Phase 3 |
0.7721 |
Intermediate Similarity |
NPD2861 |
Phase 2 |
0.7717 |
Intermediate Similarity |
NPD7843 |
Approved |
0.7697 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7697 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7697 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.7697 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7692 |
Intermediate Similarity |
NPD5536 |
Phase 2 |
0.7687 |
Intermediate Similarity |
NPD4749 |
Approved |
0.7686 |
Intermediate Similarity |
NPD1242 |
Phase 1 |
0.7681 |
Intermediate Similarity |
NPD6410 |
Clinical (unspecified phase) |
0.7676 |
Intermediate Similarity |
NPD3539 |
Phase 1 |
0.7674 |
Intermediate Similarity |
NPD7157 |
Approved |
0.7671 |
Intermediate Similarity |
NPD4357 |
Discontinued |
0.7669 |
Intermediate Similarity |
NPD3705 |
Approved |
0.7647 |
Intermediate Similarity |
NPD7975 |
Clinical (unspecified phase) |
0.7639 |
Intermediate Similarity |
NPD4237 |
Approved |
0.7639 |
Intermediate Similarity |
NPD4236 |
Phase 3 |
0.761 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.7603 |
Intermediate Similarity |
NPD7124 |
Phase 2 |
0.76 |
Intermediate Similarity |
NPD4675 |
Approved |
0.76 |
Intermediate Similarity |
NPD4678 |
Approved |
0.7595 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.7595 |
Intermediate Similarity |
NPD7228 |
Approved |
0.7571 |
Intermediate Similarity |
NPD4060 |
Phase 1 |
0.7556 |
Intermediate Similarity |
NPD3600 |
Clinical (unspecified phase) |
0.7554 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.7551 |
Intermediate Similarity |
NPD1511 |
Approved |
0.7547 |
Intermediate Similarity |
NPD7054 |
Approved |
0.7537 |
Intermediate Similarity |
NPD1091 |
Approved |
0.7535 |
Intermediate Similarity |
NPD4536 |
Approved |
0.7535 |
Intermediate Similarity |
NPD4537 |
Clinical (unspecified phase) |
0.7535 |
Intermediate Similarity |
NPD4538 |
Approved |
0.7517 |
Intermediate Similarity |
NPD5177 |
Phase 3 |
0.7517 |
Intermediate Similarity |
NPD5698 |
Clinical (unspecified phase) |
0.7516 |
Intermediate Similarity |
NPD6374 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD2674 |
Phase 3 |
0.75 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.75 |
Intermediate Similarity |
NPD7472 |
Approved |
0.7483 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.748 |
Intermediate Similarity |
NPD940 |
Approved |
0.748 |
Intermediate Similarity |
NPD846 |
Approved |
0.746 |
Intermediate Similarity |
NPD290 |
Approved |
0.7451 |
Intermediate Similarity |
NPD2978 |
Approved |
0.7451 |
Intermediate Similarity |
NPD2977 |
Approved |
0.745 |
Intermediate Similarity |
NPD1512 |
Approved |
0.7447 |
Intermediate Similarity |
NPD2238 |
Phase 2 |
0.7432 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7417 |
Intermediate Similarity |
NPD6055 |
Clinical (unspecified phase) |
0.7415 |
Intermediate Similarity |
NPD6190 |
Approved |
0.7415 |
Intermediate Similarity |
NPD2219 |
Phase 1 |
0.7413 |
Intermediate Similarity |
NPD6111 |
Discontinued |
0.7407 |
Intermediate Similarity |
NPD422 |
Phase 1 |
0.7403 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.74 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7397 |
Intermediate Similarity |
NPD4162 |
Approved |
0.7397 |
Intermediate Similarity |
NPD6674 |
Discontinued |
0.7394 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.7391 |
Intermediate Similarity |
NPD6584 |
Phase 3 |
0.7388 |
Intermediate Similarity |
NPD6516 |
Phase 2 |
0.7388 |
Intermediate Similarity |
NPD5846 |
Approved |
0.7379 |
Intermediate Similarity |
NPD2029 |
Clinical (unspecified phase) |
0.7372 |
Intermediate Similarity |
NPD8651 |
Approved |
0.7361 |
Intermediate Similarity |
NPD5960 |
Phase 3 |
0.7361 |
Intermediate Similarity |
NPD5588 |
Approved |
0.7361 |
Intermediate Similarity |
NPD1510 |
Phase 2 |
0.7355 |
Intermediate Similarity |
NPD2860 |
Approved |
0.7355 |
Intermediate Similarity |
NPD2859 |
Approved |
0.7347 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7346 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.7344 |
Intermediate Similarity |
NPD4750 |
Phase 3 |
0.7342 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.7339 |
Intermediate Similarity |
NPD291 |
Approved |
0.7338 |
Intermediate Similarity |
NPD9494 |
Approved |
0.7329 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.7324 |
Intermediate Similarity |
NPD1240 |
Approved |
0.7317 |
Intermediate Similarity |
NPD3020 |
Approved |
0.7315 |
Intermediate Similarity |
NPD7212 |
Phase 2 |
0.7315 |
Intermediate Similarity |
NPD7213 |
Phase 3 |
0.7305 |
Intermediate Similarity |
NPD5110 |
Phase 2 |
0.7305 |
Intermediate Similarity |
NPD3145 |
Approved |
0.7305 |
Intermediate Similarity |
NPD3144 |
Approved |
0.7305 |
Intermediate Similarity |
NPD5111 |
Phase 2 |
0.7305 |
Intermediate Similarity |
NPD5109 |
Approved |
0.7301 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.7297 |
Intermediate Similarity |
NPD5241 |
Discontinued |
0.7296 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7286 |
Intermediate Similarity |
NPD5752 |
Clinical (unspecified phase) |
0.7279 |
Intermediate Similarity |
NPD1652 |
Phase 2 |
0.7273 |
Intermediate Similarity |
NPD5735 |
Approved |
0.7273 |
Intermediate Similarity |
NPD2934 |
Approved |
0.7273 |
Intermediate Similarity |
NPD9296 |
Approved |
0.7273 |
Intermediate Similarity |
NPD5124 |
Phase 1 |
0.7273 |
Intermediate Similarity |
NPD2933 |
Approved |
0.7273 |
Intermediate Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.7273 |
Intermediate Similarity |
NPD6671 |
Approved |
0.7267 |
Intermediate Similarity |
NPD7447 |
Phase 1 |
0.7267 |
Intermediate Similarity |
NPD4123 |
Phase 3 |
0.726 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.726 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.7256 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.7256 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.7248 |
Intermediate Similarity |
NPD5058 |
Phase 3 |
0.7244 |
Intermediate Similarity |
NPD968 |
Approved |
0.7239 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.7234 |
Intermediate Similarity |
NPD7095 |
Approved |
0.723 |
Intermediate Similarity |
NPD4109 |
Clinical (unspecified phase) |
0.723 |
Intermediate Similarity |
NPD6331 |
Phase 2 |
0.723 |
Intermediate Similarity |
NPD3892 |
Phase 2 |
0.723 |
Intermediate Similarity |
NPD4110 |
Phase 3 |
0.7226 |
Intermediate Similarity |
NPD6818 |
Clinical (unspecified phase) |
0.7222 |
Intermediate Similarity |
NPD1607 |
Approved |
0.7219 |
Intermediate Similarity |
NPD5261 |
Clinical (unspecified phase) |
0.7211 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.7209 |
Intermediate Similarity |
NPD5451 |
Approved |
0.7205 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.7203 |
Intermediate Similarity |
NPD3062 |
Approved |
0.7203 |
Intermediate Similarity |
NPD3061 |
Approved |
0.7203 |
Intermediate Similarity |
NPD3059 |
Approved |
0.7203 |
Intermediate Similarity |
NPD943 |
Approved |
0.7197 |
Intermediate Similarity |
NPD4055 |
Discovery |
0.7197 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.7197 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.7194 |
Intermediate Similarity |
NPD3094 |
Phase 2 |
0.7183 |
Intermediate Similarity |
NPD6798 |
Discontinued |
0.7181 |
Intermediate Similarity |
NPD2677 |
Approved |
0.7174 |
Intermediate Similarity |
NPD6582 |
Phase 2 |
0.7174 |
Intermediate Similarity |
NPD6583 |
Phase 3 |
0.7153 |
Intermediate Similarity |
NPD3092 |
Approved |
0.7153 |
Intermediate Similarity |
NPD6355 |
Discontinued |
0.7153 |
Intermediate Similarity |
NPD3657 |
Discovery |
0.7152 |
Intermediate Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.7143 |
Intermediate Similarity |
NPD1375 |
Discontinued |
0.7143 |
Intermediate Similarity |
NPD5762 |
Approved |
0.7143 |
Intermediate Similarity |
NPD5763 |
Approved |
0.7133 |
Intermediate Similarity |
NPD6233 |
Phase 2 |
0.7133 |
Intermediate Similarity |
NPD1726 |
Clinical (unspecified phase) |
0.7132 |
Intermediate Similarity |
NPD9381 |
Approved |
0.7132 |
Intermediate Similarity |
NPD9384 |
Approved |
0.7124 |
Intermediate Similarity |
NPD3686 |
Approved |
0.7124 |
Intermediate Similarity |
NPD3687 |
Approved |
0.7122 |
Intermediate Similarity |
NPD2922 |
Phase 1 |
0.7115 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7115 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.7107 |
Intermediate Similarity |
NPD5494 |
Approved |
0.7105 |
Intermediate Similarity |
NPD1940 |
Clinical (unspecified phase) |
0.7103 |
Intermediate Similarity |
NPD5314 |
Approved |
0.7103 |
Intermediate Similarity |
NPD2568 |
Approved |
0.7101 |
Intermediate Similarity |
NPD2235 |
Phase 2 |
0.7101 |
Intermediate Similarity |
NPD2231 |
Phase 2 |
0.7091 |
Intermediate Similarity |
NPD7240 |
Approved |
0.7086 |
Intermediate Similarity |
NPD6799 |
Approved |
0.7083 |
Intermediate Similarity |
NPD5837 |
Clinical (unspecified phase) |
0.708 |
Intermediate Similarity |
NPD3847 |
Discontinued |
0.7078 |
Intermediate Similarity |
NPD7261 |
Clinical (unspecified phase) |
0.7075 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.7075 |
Intermediate Similarity |
NPD6100 |
Approved |
0.7075 |
Intermediate Similarity |
NPD2161 |
Phase 2 |
0.7075 |
Intermediate Similarity |
NPD6099 |
Approved |
0.7075 |
Intermediate Similarity |
NPD2796 |
Approved |
0.707
|
Intermediate Similarity |
NPD2560 |
Approved |